| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO R EUR CAP | RVI EMERGENTES | 43,20% | 68,84% | 31,12% | · |
| GVC GAESCO BLUE CHIPS RVMI, FI | MIXTO AGRESIVO GLOBAL | 19,69% | 37,86% | 31,12% | · |
| SABADELL EUROPA BOLSA, FI BASE | RVI EUROPA | 13,17% | 22,27% | 31,12% | 54,94% |
| AB SICAV I-EUROZONE GROWTH PORTFOLIO IX USD | RV EURO | 6,39% | 24,42% | 31,11% | 102,49% |
| DWS ESG BIOTECH TFC | RVI BIOTECNOLOGÍA | 34,66% | 23,69% | 31,11% | · |
| LO FUNDS - EMERGING HIGH CONVICTION (USD) M CAP | RVI EMERGENTES | 44,93% | 78,61% | 31,11% | 109,34% |
| PICTET - PACIFIC EX JAPAN INDEX R USD | RVI ASIA EX-JAPÓN | 14,67% | 30,29% | 31,11% | 100,05% |
| SCHRODER ISF GLOBAL DIVERSIFIED GROWTH A ACC CHF (HEDGED) | MIXTO FLEXIBLE | 16,09% | 28,75% | 31,11% | 50,57% |
| UBS (LUX) LATIN AMERICA CORPORATE BOND Q-ACC | RFI LATINOAMÉRICA | 7,55% | 24,00% | 31,10% | · |
| FIDELITY FUNDS-EUROPEAN DIVIDEND A-MINC(G)-EUR | RVI EUROPA VALOR | -0,65% | 24,06% | 31,09% | 41,98% |
